SCHEMBL864788

SCHEMBL864788

CCCC(NC(=O)C(C#N)=Cc1cccc(F)n1)c1ccc(OCCN(CC)CC)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP9X Q93008 10/20 0.56
UCHL1 P09936 1/20 0.56
USP5 P45974 1/20 0.56
USP24 Q9UPU5 1/20 0.48
STAT3 P40763 1/20 0.40
ALDH1A1 P00352 1/20 0.37
KMT2A Q03164 1/20 0.37
ACACB O00763 1/20 0.36
HRH3 Q9Y5N1 1/20 0.35
CHEK1 O14757 1/20 0.35
MAP4K4 O95819 1/20 0.35
LCK P06239 1/20 0.35
CSF1R P07333 1/20 0.35
PIM1 P11309 1/20 0.35
PHKG2 P15735 1/20 0.35
MARK3 P27448 1/20 0.35
KDR P35968 1/20 0.35
FLT3 P36888 1/20 0.35
CLK2 P49760 1/20 0.35
GSK3A P49840 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL864787 1.00 USP9X (0.56) USP9XUCHL1USP5USP24STAT3
SCHEMBL882205 0.93 USP9X (0.57) USP9XUCHL1USP5USP24STAT3
SCHEMBL10124917 0.92 USP9X (0.61) USP9XUCHL1USP5USP24STAT3
SCHEMBL10124903 0.92 USP9X (0.61) USP9XUCHL1USP5USP24STAT3
SCHEMBL20171589 0.91 USP9X (0.57) USP9XUCHL1USP5USP24STAT3
SCHEMBL882295 0.90 USP9X (0.56) USP9XUCHL1USP5USP24STAT3
SCHEMBL863498 0.90 USP9X (0.71) USP9XUCHL1USP5USP24STAT3
SCHEMBL863497 0.90 USP9X (0.71) USP9XUCHL1USP5USP24STAT3
SCHEMBL882305 0.90 USP9X (0.54) USP9XUCHL1USP5USP24STAT3
SCHEMBL10124902 0.89 USP9X (0.59) USP9XUCHL1USP5USP24STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2619184-B1 DEUBIQUITINASE INHIBITORS AND METHODS FOR USE OF THE SAME UNIV MICHIGAN REGENTS (US) 2018-05-23 EP disclosed
US-20140357673-A1 Deubiquitinase Inhibitors and Methods for Use of the Same UNIV MICHIGAN (US) 2014-12-04 US disclosed
US-8809377-B2 Deubiquitinase inhibitors and methods for use of the same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2014-08-19 US disclosed
US-20120077806-A1 Deubiquitinase Inhibitors and Methods for Use of the Same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140357673-A1 Deubiquitinase Inhibitors and Methods for Use of the Same UCHL1, USP2, USP1 USP9X 33/4885UCHL1 1/4885USP5 19/4885
US-20120077806-A1 Deubiquitinase Inhibitors and Methods for Use of the Same UCHL1, USP2, USP1 USP9X 33/4885UCHL1 1/4885USP5 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.